1. Home
  2. Labeler Index
  3. Northwind Pharmaceuticals
  4. 51655-655
  5. Product Images: Valsartan And Hydrochlorothiazide

Product Images Valsartan And Hydrochlorothiazide

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Valsartan And Hydrochlorothiazide NDC 51655-655 by Northwind Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label - 51655 655 52 Master Bottle Label Approval Rev B 05 21

Label - 51655 655 52 Master Bottle Label Approval Rev B 05 21

This is a package of Valsartan and Hydrochlorothiazide Tablets, USP with 320mg and 25mg doses. The package contains 30 tablets and is for prescription-only use. The dosage and package insert should be followed. The tablets should be stored at 7-25°C (68°F), and excursions are permitted to 15°-30°C (59°-86°F). The drug should be kept in the original container, protected from moisture, and out of children's reach. The drug's details, such as its NDC, LCN#, Rev. B, GTIN, S/N, EXP and LOT are provided on the package. The drug is repackaged by Northwind Pharmaceuticals under the Macleods Pharma USA, Inc., lot number, 33342-078-xx.*

figure-1 - valsartan hctz figure 1

figure-1 - valsartan hctz figure 1

This is a chart displaying blood pressure readings for a clinical trial. The medication being tested is Valsartan HCT at a dose of 320/25 mg. The chart displays the average blood pressure readings at each level from 140 to 180 mmHg. There is also a placebo group included in the trial.*

figure-2 - valsartan hctz figure 2

figure-2 - valsartan hctz figure 2

This is a table showing the baseline diastolic blood pressure (DBP) readings of a group of patients before treatment. The data includes four treatment options: oral medications containing 320 mg of valsartan, oral medications containing 320 mg of valsartan in combination with 25 mg of hydrochlorothiazide, oral medications containing only 25 mg of hydrochlorothiazide, and placebo. The target DBP for treatment is less than 90 mmHg.*

figure-3 - valsartan hctz figure 3

figure-3 - valsartan hctz figure 3

This is a table showing the different medications and dosages used in a medical study. It includes Valsartan and Hydrochlorothiazide among others. The last row shows the baseline SBP (Systolic Blood Pressure) measured in mmHg.*

figure-4 - valsartan hctz figure 4

figure-4 - valsartan hctz figure 4

This appears to be a table that shows baseline diastolic blood pressure (DBP) readings in mmHg for different medications, including Valsartan HCT, Valsartan, Hydrochlorothiazide, and a placebo group. The DBP readings range from 95 to 105 mmHg.*

hctz-stru - valsartan hctz hydrochlorothiazide

hctz-stru - valsartan hctz hydrochlorothiazide

valsartan-str - valsartan hctz valsartan

valsartan-str - valsartan hctz valsartan

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.